Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 13.

Journal Article

Behringer, K., Thielen, I., Mueller, H., Goergen, H., Eibl, A. D., Rosenbrock, J., Halbsguth, T., Eichenauer, D. A., Fuchs, M., Reiners, K. S., Renno, J. H., van der Ven, K., Kuehr, M., von Wolff, M., Diehl, V., Engert, A. and Borchmann, P. (2020). Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial (vol 23, pg 1818, 2012). Ann. Oncol., 31 (8). S. 1093 - 1094. AMSTERDAM: ELSEVIER. ISSN 1569-8041

Boell, B., Pluetschow, A., Eichenauer, D. A., Thielen, I, von Tresckow, B., Atta, J., Pfreundschuh, M., Feuring-Buske, M., Vogelhuber, M., Soekler, M., Fuchs, M., Engert, A. and Borchmann, P. (2014). German Hodgkin Study Group Phase I trial of Doxorubicin, Vinblastine, Dacarbazine, and Lenalidomide (AVD-Rev) for elderly Hodgkin Lymphoma patients. Oncol. Res. Treat., 37. S. 12 - 13. BASEL: KARGER. ISSN 2296-5262

Eichenauer, D. A., Aleman, B. M. P., Andre, M., Federico, M., Hutchings, M., Illidge, T., Engert, A. and Ladetto, M. (2018). Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 29. S. 19 - 30. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

Eichenauer, D. A., Engert, A., Andre, M., Federico, M., Illidge, T., Hutchings, M. and Ladetto, M. (2014). Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 25. S. 70 - 76. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

Eichenauer, D. A., Engert, A. and Dreyling, M. (2011). Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 22. S. vi55 - 4. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

Eichenauer, D. A., Goergen, H., Pluetschow, A., Wongso, D., Behringer, K., Kreissl, S., Thielen, I., Halbsguth, T., Broeckelmann, P. J., Fuchs, M., Boell, B., von Tresckow, B., Borchmann, P. and Engert, A. (2016). Ofatumumab in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: results of a phase II study from the German Hodgkin study group. Leukemia, 30 (6). S. 1425 - 1429. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Eichenauer, D. A., Kreissl, S., Buehnen, I., Baues, C., Kobe, C., van Heek, L., Goergen, H., Fuchs, M., Hartmann, S., von Tresckow, B., Engert, A. and Borchmann, P. (2021). PET-2-guided escalated BEACOPP for advanced nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the randomized German Hodgkin Study Group HD18 study. Ann. Oncol., 32 (6). S. 807 - 811. AMSTERDAM: ELSEVIER. ISSN 1569-8041

Eichenauer, D. A., Kreissl, S., Buehnen, I., Goergen, H., Hartmann, S., Fuchs, M., von Tresckow, B., Engert, A. and Borchmann, P. (2020). PET-2-guided escalated BEACOPP for patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group. Oncol. Res. Treat., 43 (SUPPL 4). S. 87 - 89. BASEL: KARGER. ISSN 2296-5262

Eichenauer, D. A., Lachmann, G. and La Rosee, P. (2021). Hemophagocytic lymphohistiocytosis in critically ill patients. Med. Klin.-Intensivmed Notfallmed., 116 (2). S. 129 - 135. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2193-6226

Eichenauer, D. A., Pluetschow, A., Fuchs, M., von Tresckow, B., Borchmann, P. and Engert, A. (2017). Long-term outcome of patients with early-stage nodular lymphocyte-predominant hodgkin lymphoma (NLPHL) treated within the randomized HD7, HD10 and HD13 trials: An analysis from the German Hodgkin Study Group (GHSG). Oncol. Res. Treat., 40. S. 142 - 143. BASEL: KARGER. ISSN 2296-5262

Eichenauer, D. A., Pluetschow, A., Fuchs, M., von Tresckow, B., Diehl, V., Borchmann, P. and Engert, A. (2017). LONG-TERM OUTCOME OF PATIENTS WITH NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA TREATED WITHIN THE RANDOMIZED HD7-HD15 TRIALS: AN ANALYSIS FROM THE GERMAN HODGKIN STUDY GROUP. Haematologica, 102. S. 82 - 83. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Kochanek, M., Shimabukuro-Vornhagen, A., Eichenauer, D. A. and Boell, B. (2020). Cardiovascular therapy for sepsis: when, how and how much? Internist, 61 (10). S. 997 - 1002. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289

Kreissl, S., Eichenauer, D. A., Meissner, J., Topp, M. S., Engert, A. and Borchmann, P. (2018). New developments in the treatment of advanced classical Hodgkin's lymphoma. Onkologe, 24 (4). S. 315 - 322. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415

This list was generated on Thu May 26 07:50:43 2022 CEST.